Literature DB >> 25700282

Trends in mortality and heart failure after acute myocardial infarction in Italy from 2001 to 2011.

Cesare Greco1, Stefano Rosato2, Paola D'Errigo2, Gian Francesco Mureddu3, Eleonora Lacorte2, Fulvia Seccareccia2.   

Abstract

BACKGROUND: Uncertainties on long-term outcomes after acute myocardial infarction (AMI) still exist, despite the ongoing progresses in the management of patients with AMI. AIM OF THE STUDY: Our aim was to appraise both the early prognosis and prognosis at 1-year after discharge of patients hospitalized due to AMI.
METHODS: This is a retrospective nationwide cohort study based on data from an administrative database on patients admitted with AMI from 2001 to 2011 in all Italian hospitals sites. Mortality and readmission rates within 30 days, 60 days and 1 year were calculated, as well as re-hospitalizations for all causes and for HF.
RESULTS: A total of 1,110,822 patients were included. Index admission mortality rate (I-MR) and total in-hospital mortality rate (T-MR) at up to 1 year both decreased respectively from 11.34% to 8.99% and from 16.46% to 14.68% in the years 2001 to 2011 (both p<0.0001), while fatal readmission rate (F-RR) at 1 year increased from 4.75% to 5.28% (p=0.0019). Patients that developed HF during the index admission had significantly higher I-MR and F-RR. I-MR, F-RR, and T-MR, however, remained low at any time point considered (30 days, 60 days and 1 year) in a subgroup of low-risk optimally-treated patients.
CONCLUSIONS: The risk of fatal readmission at 1 year increased slightly over time, in spite of the remarkable improvements currently achieved in overall prognosis after AMI. The identification of patients at high risk (mainly due to HF complicating AMI), and of patients at low risk is crucial to define and support management strategies.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acute coronary syndromes; Acute myocardial infarction; Discharge; Heart failure; Mortality; Trend

Mesh:

Year:  2015        PMID: 25700282     DOI: 10.1016/j.ijcard.2015.01.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Roles of SIRT3 in heart failure: from bench to bedside.

Authors:  De-Xing Hu; Xian-Bao Liu; Wen-Chao Song; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

2.  Effects of recombinant human brain natriuretic peptide on renal function in patients with acute heart failure following myocardial infarction.

Authors:  Yanbo Wang; Xinshun Gu; Weize Fan; Yanming Fan; Wei Li; Xianghua Fu
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

3.  Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Authors:  Michele Massimo Gulizia; Furio Colivicchi; Maurizio Giuseppe Abrignani; Marco Ambrosetti; Nadia Aspromonte; Gabriella Barile; Roberto Caporale; Giancarlo Casolo; Emilia Chiuini; Andrea Di Lenarda; Pompilio Faggiano; Domenico Gabrielli; Giovanna Geraci; Alessio Gaetano La Manna; Aldo Pietro Maggioni; Alfredo Marchese; Ferdinando Maria Massari; Gian Francesco Mureddu; Giuseppe Musumeci; Federico Nardi; Antonio Vittorio Panno; Roberto Franco Enrico Pedretti; Massimo Piredda; Enrico Pusineri; Carmine Riccio; Roberta Rossini; Fortunato Scotto di Uccio; Stefano Urbinati; Ferdinando Varbella; Giovanni Battista Zito; Leonardo De Luca
Journal:  Eur Heart J Suppl       Date:  2018-05-31       Impact factor: 1.803

4.  Current Trends for ST-segment Elevation Myocardial Infarction during the Past 5 Years in Rural Areas of China's Liaoning Province: A Multicenter Study.

Authors:  Guang-Xiao Li; Bo Zhou; Guo-Xian Qi; Bo Zhang; Da-Ming Jiang; Gui-Mei Wu; Bing Ma; Peng Zhang; Qiong-Rui Zhao; Juan Li; Ying Li; Jing-Pu Shi
Journal:  Chin Med J (Engl)       Date:  2017-04-05       Impact factor: 2.628

Review 5.  Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists.

Authors:  Margherita Neri; Irene Riezzo; Natascha Pascale; Cristoforo Pomara; Emanuela Turillazzi
Journal:  Mediators Inflamm       Date:  2017-02-13       Impact factor: 4.711

6.  Access to percutaneous transluminal coronary angioplasty and 30-day mortality in patients with incident STEMI: Differentials by educational level and gender over 11 years.

Authors:  Laura Cacciani; Nera Agabiti; Anna Maria Bargagli; Marina Davoli
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 7.  Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Lang Liu; Xiaofang Ding; Yaxiang Han; Jianfeng Lv
Journal:  J Healthc Eng       Date:  2022-01-05       Impact factor: 2.682

Review 8.  Leveraging Clinical Digitized Data to Understand Temporal Characteristics and Outcomes of Acute Myocardial Infarctions at a Tertiary Care Medical Centre in Pakistan from 1988-2018 - Methods and Results.

Authors:  Zainab Samad; Ali Aahil Noorali; Awais Farhad; Safia Awan; Nada Qaiser Qureshi; Minaz Mawani; Mushyada Ali; Laiba Masood; Ghufran Adnan; Linda K Shaw; Fahim Haider Jafary; Salim S Virani; Eric J Velazquez; Zulfiqar Bhutta; Gerald S Bloomfield; Javed Tai
Journal:  Glob Heart       Date:  2022-08-18

9.  Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China.

Authors:  Fuxue Deng; Yong Xia; Michael Fu; Yunfeng Hu; Fang Jia; Yeffry Rahardjo; Yingyi Duan; Linjing He; Jing Chang
Journal:  Exp Ther Med       Date:  2016-03-31       Impact factor: 2.447

10.  The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.

Authors:  Salvatore Soldati; Mirko Di Martino; Alessandro Cesare Rosa; Danilo Fusco; Marina Davoli; Gian Francesco Mureddu
Journal:  BMC Cardiovasc Disord       Date:  2021-09-27       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.